Loading…
P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV‐SPECIFIC T‐CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE
Saved in:
Published in: | HemaSphere 2023-08, Vol.7 (S3), p.e8073255-n/a |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 2572-9241 2572-9241 |
DOI: | 10.1097/01.HS9.0000972440.80732.55 |